(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP test) (NP (DT this) (NN hypothesis)) (PP (IN by) (S (VP (VBG analyzing) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (ADJP (JJ male) (CC and) (JJ female)) (NNS researchers)) (SBAR (WHNP (WDT that)) (S (VP (VBP publish) (NP (JJ scientific) (NNS papers)) (PP (IN during) (NP (DT the) (NN pandemic))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP use) (NP (NNS data)) (PP (IN from) (NP (NP (JJ biomedical) (JJ preprint) (NNS servers)) (CC and) (NP (NML (NNP Springer) (HYPH -) (NNP Nature)) (NNS journals)))) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NNS women)) (VP (VBG publishing) (PP (IN during) (NP (DT the) (NN pandemic))))))) (VP (VBZ drops) (ADVP (RB significantly)) (PP (IN across) (NP (NML (NNS disciplines) (CC and) (NN research)) (NNS topics))) (, ,) (PP (IN after) (S (VP (VBG controlling) (PP (IN for) (NP (JJ temporal) (NNS trends))))))))))))) (. .))
(S (NP (DT The) (NN impact)) (VP (VBZ is) (ADVP (RB particularly)) (VP (VBN pronounced) (PP (IN for) (NP (NP (JJ biomedical) (NNS papers)) (VP (VBN related) (PP (IN to) (NP (NML (NNP COVID) (HYPH -) (CD 19)) (NN research)))))))) (. .))
(S (ADVP (RB Further)) (, ,) (PP (IN by) (S (VP (VBG geocoding) (NP (NP (NN author) (POS 's)) (NNS affiliations))))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NN gender) (NNS disparities)) (VP (VBP are) (VP (VBN exacerbated) (PP (IN in) (NP (JJR poorer) (NNS countries))))))) (, ,) (RB even) (SBAR (IN though) (S (NP (DT these) (NNS countries)) (VP (VBD had) (NP (NP (JJR less)) (PP (IN of) (NP (DT a) (NN gender) (NN gap)))) (PP (IN in) (NP (NP (NN research)) (PP (JJ prior) (IN to) (NP (DT the) (NN pandemic)))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP illustrate) (SBAR (WHADVP (WRB how)) (S (NP (NP (JJ exceptional) (NNS events)) (PP (IN like) (NP (DT a) (JJ global) (NN pandemic)))) (VP (MD can) (ADVP (RB further)) (VP (VB amplify) (NP (NN gender) (NNS inequalities)) (PP (IN in) (NP (NN research)))))))) (. .))
(S (NP (PRP$ Our) (NN work)) (VP (MD could) (VP (VB inform) (NP (ADJP (JJR fairer) (JJ scientific)) (NN evaluation) (NNS practices)) (, ,) (PP (ADVP (RB especially)) (IN for) (NP (NP (NML (JJ early) (HYPH -) (NN career)) (JJ female) (NNS researchers)) (SBAR (WHNP (WP who)) (S (VP (MD may) (VP (VB be) (ADVP (RB disproportionately)) (VP (VBN affected) (PP (IN by) (NP (DT the) (NN pandemic)))))))))))) (. .))
